A Study of Olverembatinib in SDH-deficient GIST.
Clinical trial NCT06640361 · RECRUITING
Trial details
- NCT number
- NCT06640361
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-11
- Primary completion
- 2027-03-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.